tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Schwartz, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst Steven Schwartz, carries an average stock price target met ratio of 100% that have a potential upside of 72.54% achieved within 111 days. Previously, Steven Schwartz worked at OPPENHEIMER, RAYMOND JAMES.
Steven Schwartz’s has documented 8 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CTLT, Catalent at 05-Mar-2019.
Analyst best performing recommendations are on CDMO (AVID BIOSERVICES).
The best stock recommendation documented was for CDMO (AVID BIOSERVICES) at 3/13/2018. The price target of $4 was fulfilled within 111 days with a profit of $2.25 (128.57%) receiving and performance score of 11.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Nov-2024
$12
$-0.49 (-3.92%)
$12
1 years 3 months 25 days ago
(07-Nov-2024)
10/13 (76.92%)
$-0.24 (-1.96%)
27
Buy Since 14-Mar-2023
$14
$1.51 (12.09%)
$14
1 years 8 months 1 days ago
(03-Jul-2024)
4/6 (66.67%)
$6.3 (81.82%)
59
Buy
$16
$7.76 (94.17%)
$22
2 years 2 months 23 days ago
(08-Dec-2023)
2/6 (33.33%)
$11.36 (244.83%)
266
Buy
$20
$11.76 (142.72%)
$22
2 years 8 months 9 days ago
(22-Jun-2023)
1/4 (25%)
$6.26 (45.56%)
92
Buy Since 17-Jul-2018
$9
$-3.49 (-27.94%)
$11
5 years 11 months 21 days ago
(11-Mar-2020)
3/3 (100%)
$4.49 (99.56%)
356
What Year was the first public recommendation made by Steven Schwartz?
